glp 1 patents Patent and Innovation Trends in GLP-1 and Weight Loss Drugs (2020–2025) GLP-1 Receptor Agonists and Patent
Description
[2] KFF Employer Health Benefits Survey, 2025
Recent investigations by UK and U.S
In consideration of the dual roles of GLP-1RAs in hypoglycemic effects and preventing CVD among T2DM patients, we reviewed the cardiovascular effects and molecular mechanisms of GLP-1RAs in CVOTs, animal models and cultured cells, and discuss how these findings transform pharmacotherapies for T2DM, and even expand the indication of this important category of anti-diabetic drugs to CVD patients without diabetes
and acknowledgement that patient equity considerations must be balanced against theoretical safety concerns [48]
Enhancing permeation of drug molecules across the skin via delivery in nanocarriers: novel strategies for effective transdermal applications
